Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Spectral AI, Inc. (MDAI : NSDQ)

• Company Description    Spectral MD Holdings Ltd. is a predictive AI company focused on medical diagnostics. The Company's DeepView(R) platform is a predictive diagnostic device which offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. Spectral MD Holdings Ltd., formerly known as ROSECLIFF ACQ, is based in DALLAS. Number of Employees: 78

• Price / Volume Information    Yesterday's Closing Price: $1.42 Daily Weekly Monthly 20 Day Moving Average: 268,222 shares Shares Outstanding: 30.69 (millions) Market Capitalization: $43.58 (millions) Beta: 0.94 52 Week High: $3.21 52 Week Low: $1.04 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.98% -15.83% 12 Week -42.04% -42.97% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2515 McKinney Avenue Suite 1000 - Dallas,TX 75201 USA ph: 972-499-4934 fax: - ir@spectral-ai.com http://www.spectral-ai.com

• General Corporate Information    Officers J. Michael DiMaio - Principal Executive Officer and Chairman Vincent Capone - Chief Financial Officer Richard Cotton - Director Martin Mellish - Director Deepak Sadagopan - Director Peer Information Spectral AI, Inc. (ABMD) Spectral AI, Inc. (DMDS) Spectral AI, Inc. (CPWY.) Spectral AI, Inc. (EQUR) Spectral AI, Inc. (ECIA) Spectral AI, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 84757T105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/26/26 Share - Related Items Shares Outstanding: 30.69 Most Recent Split Date: (:1) Beta: 0.94 Market Capitalization: $43.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.47 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/26/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.88 EPS Growth vs. Year Ago Period: -550.00% vs. Previous Quarter: -30.00% Sales Growth vs. Year Ago Period: -53.60% vs. Previous Quarter: -25.13% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - -27.57 06/30/25 - -8.69 Current Ratio 12/31/25 - - 09/30/25 - 0.85 06/30/25 - 0.87 Quick Ratio 12/31/25 - - 09/30/25 - 0.83 06/30/25 - 0.84 Operating Margin 12/31/25 - - 09/30/25 - -19.08 06/30/25 - -4.77 Net Margin 12/31/25 - - 09/30/25 - -70.64 06/30/25 - -51.97 Pre-Tax Margin 12/31/25 - - 09/30/25 - -69.79 06/30/25 - -51.13 Book Value 12/31/25 - - 09/30/25 - -0.27 06/30/25 - -0.36 Inventory Turnover 12/31/25 - - 09/30/25 - 28.66 06/30/25 - 34.13 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©